Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06699251 · ClinicalTrials.gov registry record · NA

Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)

A NA study of Cannabis Use and Adolescent Drinking, sponsored by RAND.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
2
Study locations

NCT06699251: Recruiting NA study of Cannabis Use and Adolescent Drinking, sponsored by RAND.

NCT06699251 is a NA study of Cannabis Use and Adolescent Drinking that is actively recruiting participants, run by RAND. The registered enrollment target is 500 participants, above the 268-participant average among 44 other Cannabis Use trials with a reported enrollment target (87% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06699251, a NA study of Cannabis Use and Adolescent Drinking, is actively recruiting participants, sponsored by RAND.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
2
Study locations

Study Summary

Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.

Primary Outcome

We will assess both the number of times participants have used alcohol in the past three months (from none to 31 or more times) and the number of days in the past month participants report use of alcohol.

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Chat

Study Locations (2)

California

  • AltaMed Health Services - Commerce

Pennsylvania

  • University of Pittsburgh Medical Center Children's Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-04-28
Est. Completion 2029-02-28
Phase NA
RAND

78 total trials

What NCT06699251 shows while recruiting

NCT06699251 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 268-participant average among 44 other Cannabis Use trials with a reported enrollment target (87% higher).

The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06699251 reports a single indexed study location in California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06699251 about?

NCT06699251 is a clinical study titled "Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)". Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.

What is the current status of trial NCT06699251?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-28. Estimated completion is 2029-02-28.

What conditions does trial NCT06699251 study?

This clinical trial studies the following conditions: Cannabis Use, Adolescent Drinking.

What interventions are being tested in trial NCT06699251?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Chat (BEHAVIORAL).

Who is sponsoring clinical trial NCT06699251?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06699251 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06699251's enrollment target sits among peer trials

500 5th of 44 higher than 40 of 44 other Cannabis Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06699251, the US trial registry maintained by the National Library of Medicine. NCT06699251 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.